期刊文献+

积极降压在防治糖尿病肾病中的作用 被引量:6

下载PDF
导出
摘要 糖尿病肾病是糖尿病最主要的微血管并发症之一,它是导致慢性肾衰竭发生的主要原因,这种趋势在我国也越来越明显。糖尿病与高血压常合并存在。流行病学调查显示,在糖尿病人群中,高血压发生率比年龄匹配的非糖尿病人群高1.5-3倍。
作者 裴娟 张燕林
出处 《内科急危重症杂志》 2014年第4期223-226,共4页 Journal of Critical Care In Internal Medicine
  • 相关文献

参考文献22

  • 1KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease [ J ]. Am J Kidney Dis ,2007,49 ( 2 suppl 2 ) : S12-S154.
  • 2Bakris GL,Weir MR,Shanifar S,et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL Study [ J ]. Arch Intern Med,2003,163 ( 13 ) : 1555-1565.
  • 3Shankar A, Klein R, Klein BE. Relationship between low-normal blood pressure and kidney disease in type 1 diabetes. Hypertension [ J ]. 2007,49( 1 ) :48-54.
  • 4UKPDS:UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38[J]. BMJ. 1998,317(7160) :703-713.
  • 5Staessen JA, Fagard R,Thijs L,et al. Randomised double-blind com- parison of placebo and active treatment for older patients with isolated systolic hypertension The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. [ J ]. Lancet, 1997,350 (9080) :757-764.
  • 6Bakris GL,Williams M,Dworkin L,et al. Preserving renal function in a- dults with hypertension and diabetes : a consensus approach. National kid- ney foundation hypertension and diabetes executive committees working group[J]. Am J Kidney Dis,20O,36(3):6464561.
  • 7Bakris GL, Sowers JR. American Society of Hypertension Writing Group, ASH position paper: treatment of hypertension in patients with diabetes-an update[ J]. J Clini Hypertens ,2008,10(9 ) : 707-713.
  • 8American Diabetes Association, Standards of Medical Care in Diabe- tes-2009 [ J ]. Diabetes Care January, 2009,32 ( suppl 1 ) : S 13 -S61.
  • 9KDIGO BP Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease [ J ]. Kidney Int Supp1,2012,2(5) :337414.
  • 10James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8),2014,311 (5):507-520.

同被引文献41

  • 1刘志红.糖尿病肾病的治疗[J].中国实用内科杂志,2006,26(3):322-323. 被引量:102
  • 2Reidy K, Kang HM, Hostetter T, et al. Molecular mechanisms of dia- betic kidney disease [ J ]. J Clin Invest,2014,124 ( 6 ) :2333-2340.
  • 3Opelz G, Dohler B. Renin-Angiotensin system blockers and cardiovas- cular death in kidney recipients [ J ]. Transplantation. 2014,97 ( 1 ) : 62-63.
  • 4Ortiz-Melo DI, Spunley RF. Special deLIVERy: podocyte injury pro- motes renal angiotensin II generation from liver-derived angiotensino- gen [ J ]. Kidney Int ,2014,85 ( 5 ) : 1009-1011.
  • 5Wanitchanont A,Somparn P, Vadcharavivad S, et al. Effects of atorv- astatin on the pharmacokinetics of everolimus among kidney transplant recipients[J]. Transplant Proc,2014,46(2) :418-421.
  • 6Huo X, Liu Q, Wang C, et al. Inhibitory effect of valsartan on the in- testinal absorption and renal excretion of bestatin in rats [J]. J Pharm Sci,2014,103 (2) :719-729.
  • 7郭丽.糖尿病肾病性高血压的发病机制研究进展[J].中国保健营养,2013,23(11):7009-7010.
  • 8Sun L,Zhang D,Liu F,et al. 1,ow-dose paclitaxcl ameliorates fibrosis in the remnant kidney model |/5, down-regnlaling miR-192 [ J ]. J Pathol, 2011,225 ( 3 ) : 364-377.
  • 9Zhcng C, Li X, Kong C ,et al. Effect of single nucleotide tolymorphisnl in ttlrombin-activatable fibrinolysis inhibitor on lhe risk of diabetic macrovascular disease[ J ]. Blood Coagul Fibrinolysis, 2015,26 ( 2 ) : 185-190.
  • 10Xu CW, Wu XB, Ma XL, eta]. Genetic variation in thromlin-aetivat- able fibrinolysis inhibitor is associated with tile risk of diabetic ne- phrofathy [ J ]. J Endocrinol Invest ,2012,35 ( 7 ) :620-624.

引证文献6

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部